153 related articles for article (PubMed ID: 38055066)
41. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
42. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
[TBL] [Abstract][Full Text] [Related]
43. The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer.
Miyahara Y; Takashi S; Shimizu Y; Ohtsuka M
World J Surg Oncol; 2020 Apr; 18(1):78. PubMed ID: 32321522
[TBL] [Abstract][Full Text] [Related]
44. Neutrophil/lymphocyte ratio is a more sensitive systemic inflammatory response biomarker than platelet/lymphocyte ratio in the prognosis evaluation of unresectable pancreatic cancer.
Gao Y; Wang WJ; Zhi Q; Shen M; Jiang M; Bian X; Gong FR; Zhou C; Lian L; Wu MY; Feng J; Tao M; Li W
Oncotarget; 2017 Oct; 8(51):88835-88844. PubMed ID: 29179480
[TBL] [Abstract][Full Text] [Related]
45. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model].
Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796
[No Abstract] [Full Text] [Related]
46. Systemic Inflammatory Biomarkers as Surrogate Markers for Stage in Colon Cancer.
Uludag SS; Sanli AN; Zengin AK; Ozcelik MF
Am Surg; 2022 Jun; 88(6):1256-1262. PubMed ID: 33596111
[TBL] [Abstract][Full Text] [Related]
47. Serum lactate dehydrogenase predicts prognosis and correlates with systemic inflammatory response in patients with advanced pancreatic cancer after gemcitabine-based chemotherapy.
Yu SL; Xu LT; Qi Q; Geng YW; Chen H; Meng ZQ; Wang P; Chen Z
Sci Rep; 2017 Mar; 7():45194. PubMed ID: 28345594
[TBL] [Abstract][Full Text] [Related]
48. Effect of C-reactive protein/albumin ratio on prognosis in advanced non-small-cell lung cancer.
Ni XF; Wu J; Ji M; Shao YJ; Xu B; Jiang JT; Wu CP
Asia Pac J Clin Oncol; 2018 Dec; 14(6):402-409. PubMed ID: 30178541
[TBL] [Abstract][Full Text] [Related]
49. Anamorelin in Japanese patients with cancer cachexia: an update.
Wakabayashi H; Arai H; Inui A
Curr Opin Support Palliat Care; 2023 Sep; 17(3):162-167. PubMed ID: 37389636
[TBL] [Abstract][Full Text] [Related]
50. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
[TBL] [Abstract][Full Text] [Related]
51. The relation between inflammation-based parameters and survival in metastatic pancreatic cancer.
Turker S; Cilbir E; Guven DC; Karacin C; Yalcin S
J Cancer Res Ther; 2021; 17(2):510-515. PubMed ID: 34121700
[TBL] [Abstract][Full Text] [Related]
52. Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma.
Zhang X; Gari A; Li M; Chen J; Qu C; Zhang L; Chen J
J Transl Med; 2022 Feb; 20(1):61. PubMed ID: 35109887
[TBL] [Abstract][Full Text] [Related]
53. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma.
Pointer DT; Roife D; Powers BD; Murimwa G; Elessawy S; Thompson ZJ; Schell MJ; Hodul PJ; Pimiento JM; Fleming JB; Malafa MP
BMC Cancer; 2020 Aug; 20(1):750. PubMed ID: 32782024
[TBL] [Abstract][Full Text] [Related]
54. Prognostic value of the C-reactive protein/Albumin Ratio (CAR) in patients with operable soft tissue sarcoma.
Liang Y; Xiao W; Guan YX; Wang W; Chen HY; Fang C; Zhang X; Zhou ZW
Oncotarget; 2017 Nov; 8(58):98135-98147. PubMed ID: 29228679
[TBL] [Abstract][Full Text] [Related]
55. [Establishment of a nomogram model for predicting lymph node metastasis in patients with cN0 gastric cancer based on combination of preoperative C-reactive protein/albumin ratio].
Liu Q; Peng J; Jiang HG; Wang WB; Dai J; Zhou FX
Zhonghua Zhong Liu Za Zhi; 2019 Aug; 41(8):599-603. PubMed ID: 31434451
[No Abstract] [Full Text] [Related]
56. Systemic Inflammation Biomarkers Predict Survival in Patients of Early Stage Non-Small Cell Lung Cancer Treated With Stereotactic Ablative Radiotherapy - A Single Center Experience.
Luo H; Ge H; Cui Y; Zhang J; Fan R; Zheng A; Zheng X; Sun Y
J Cancer; 2018; 9(1):182-188. PubMed ID: 29290784
[No Abstract] [Full Text] [Related]
57. Factors associated with early discontinuation of anamorelin in patients with cancer-associated cachexia.
Tsukiyama I; Iwata T; Takeuchi T; Kato RI; Sakuma M; Tsukiyama S; Kato M; Ikeda Y; Ohashi W; Kubo A; Mori N
Support Care Cancer; 2023 Oct; 31(12):621. PubMed ID: 37815652
[TBL] [Abstract][Full Text] [Related]
58. Anamorelin for cancer cachexia.
Nishie K; Sato S; Hanaoka M
Drugs Today (Barc); 2022 Mar; 58(3):97-104. PubMed ID: 35274629
[TBL] [Abstract][Full Text] [Related]
59. Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic Cancer.
Fan Z; Luo G; Gong Y; Xu H; Qian Y; Deng S; Huang Q; Yang C; Cheng H; Jin K; Liu C; Yu X
Ann Surg Oncol; 2020 Oct; 27(10):4017-4025. PubMed ID: 32144621
[TBL] [Abstract][Full Text] [Related]
60. Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI).
Mandaliya H; Jones M; Oldmeadow C; Nordman II
Transl Lung Cancer Res; 2019 Dec; 8(6):886-894. PubMed ID: 32010567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
